AI Autism & Developmental Screening in India

The early intervention window

Neurodevelopmental conditions such as autism spectrum disorder, ADHD, and speech-language delays are most responsive to intervention in the earliest years of life, when brain plasticity is at its peak. Global health bodies estimate that roughly 1 in 100 children is on the autism spectrum, and developmental delays affect many more. Yet in India, the average age of diagnosis remains years after the first signs appear.

The reasons are structural: too few developmental specialists concentrated in metros, long waiting lists, high assessment costs, and low awareness of what early signs look like. A child in a Tier-2 city or village may wait years for an evaluation that a family in South Delhi gets in weeks.

What Neurolens is

Neurolens is Gabify’s AI-powered developmental screening platform. Instead of requiring an in-person specialist visit as the first step, Neurolens allows structured screening — including home-visit recording workflows — that AI analyses across developmental domains, producing a domain-scored screening report that is then reviewed with expert consultation.

The parent journey inside Gabify runs as a clear pipeline: screening received, assigned, recorded, analysed into a report, discussed in a consult, and completed — visible at every stage in the parent dashboard.

Built on Indian data, for Indian children

Most screening tools used in India were developed and normed on Western populations. Gabify took a different path: the founding team travelled across India — including villages and anganwadis — to collect over 1 lakh datapoints across 189 parameters and 9 developmental domains, capturing India’s cultural and linguistic diversity. Clinical validation partnerships with premier Indian institutions ground the science.

This matters clinically. Eye contact norms, language mixing, feeding practices and play patterns differ across cultures; a screening model that has never seen Indian children will misread them.

Screening, not diagnosis

An important distinction: Neurolens screens; clinicians diagnose. A screening report indicates whether a child’s development warrants professional evaluation, and in which domains. Families with concerning results are connected to verified specialists through Gabify Care, and clinics using Gabify Connect can attach Neurolens cognitive screening reports directly to the child’s case file — so screening flows seamlessly into assessment, diagnosis and therapy.

What parents receive

Every Gabify screening report includes an accessible preamble — what the screening measures, what ranges mean, and a child milestone chart — so parents are never handed numbers without explanation. Reports can be produced in the family’s language, consistent with Gabify’s multilingual reporting.

Why screening at scale changes the system

When screening becomes affordable and available in every district, three things happen: children are identified years earlier, therapy begins inside the high-plasticity window, and specialist time is spent on children who need it most. That is the promise of AI screening done responsibly — awareness, accessibility and affordability working together.

If you have questions about your child’s development, do not wait and watch. Book an AI screening or talk to a verified specialist through Gabify.

AI-Powered Autism and Developmental Screening in India: How Neurolens Detects Early Signs